NCT04851951

Platelet Rich Plasma (PRP) One-Shot Injection For Supraspinatus Tendinosis

Clinical Results Of Platelet Rich Plasma (PRP) One-Shot Injection For Supraspinatus Tendinosis, Our Experience At Short-Term Follow Up

• Status: Completed
• Phase: —
• Study type: Observational
• Enrollment: 48 (actual)
• Sponsor: Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

It was conducted a prospective study with a series of 50 patients treated with PRP one-shot injection in patient affected by Supraspinatus Tendinosis. One independent observer performed clinical and functional evaluations at T0 (recruitment), T1 (one month after the injection), T2 (three months after the last injection) and T3 (six months after the last injection). Constant Score, The Disabilites of the Arm,Shoulder and Hand Score (DASH) And Visual Analogue Scale (VAS) were administered at each evaluation.

Conditions

• Supraspinatus Tendinitis

Interventions

Type	Name	Description
PROCEDURE	one-shot PRP injection	A single injection of PRP (7% concentrate) ml 4 was made in the Supraspinatus tendon and in the Subacromial space under ultrasound guidance.

Timeline

• Start date: 2018-01-01
• Primary completion: 2020-07-01
• Completion: 2021-04-01
• First posted: 2021-04-21
• Last updated: 2021-04-27

Locations

1 site across 1 country: Italy